Why the study?
Does the PlA2 polymorphism influence platelet response to thrombin receptor activation in healthy volunteers?
Does the PlA2 polymorphism influence platelet response to thrombin receptor activation in healthy volunteers?
The PlA2 polymorphism is associated with platelet hypoaggregability, while platelet secretion in response to thrombin receptor activation appears to be a genetically controlled phenotype independent of this polymorphism.
Answers are grounded in this paper and cite their sources.
PlA2 may reduce thrombin receptor-mediated platelet aggregability in healthy subjects; leaves open its clinical relevance and requires prospective outcome studies.
Considering that platelet response to thrombin receptor activation might be critical for the development of arterial thrombosis, we measured the dense granule release under stimulation by the thrombin receptor activating peptide (TRAP) in a series of 102 healthy volunteers. The threshold TRAP concentration which initiated a secretion ranged from 3 to 20 microM. A good concordance (79%, k=0.677) between two tests performed at a 1 month interval indicated that platelet response to thrombin receptor activation was characteristic of each individual donor. Since the threshold concentration required to initiate secretion corresponded to the threshold concentration which induced a biphasic aggregation, all volunteers were genotyped for the PlA2 polymorphism, the Pro33 variant of GPIIIa. Platelets from subjects with the PlA2 polymorphism required higher TRAP concentrations to aggregate than those from subjects with no PlA2 allele (P=0.0012). However, they also required a higher ADP concentration to aggregate. In order to exclude any influence of GPIIIa polymorphism on TRAP-induced secretion, we studied the variability of platelet response to TRAP among the 77 individuals with no PlA2 allele, and found the same interdonor variability with the same distribution of threshold TRAP concentrations as for the 102 individuals. The results suggest that (i) platelet secretion in response to thrombin receptor activation could be a genetically controlled phenotype independent of the GPIIIa polymorphism; (ii) the PlA2 polymorphism is associated with platelet hypoaggregability.
No takes yet. Share an insight, caveat, or question.
Lasne et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: